It's funny, we've been so focused on Brilacidin and now Prurisol, since we know we're going to get data real soon, that we kind of forget how important it is that they're still letting people get doses of Kevetrin. Who would want to continue getting a drug if they didn't think it was helping?

Drug trials usually take longer than anyone thinks they will. They're incredibly complex to run, and any little mistake and the FDA might want you to re-do the trial. People need a drug like this now. Agonizing to think that there's a drug that could help many people, but progression toward FDA approval takes so much time.